NEW YORK, April 04, 2017 -- Patrick Luthy, Financial Controller of the Americas division of Medtronic, has been selected to join the Industry Board at the American Health Council. He will be sharing his knowledge and expertise in Finance, Business, and Technology.
Medtronic is a medical device company that focuses on improving and transforming the lives of millions. Its mission is to contribute to human welfare by application of biomedical engineering in the research, design, manufacture, and sale of instruments of application that alleviate pain, restore health, and extend life. Initially started as a medical equipment repair shop in 1949, Medtronic has expanded to include medical technologies from implantable mechanical devices, surgical instruments, and biologic delivery devices.
Mr. Luthy has been active in the healthcare industry for over two decades. He earned his Master’s degree in Commercial and Industrial Finance from the University of Geneva in 1993 and completed the International Marketing Program at INSEAD in 2004. He received his Leadership Certification in High Performance Leadership from the IMD Business School.
As the Financial Controller of the Americas division of Medtronic, Mr. Luthy leads budget and forecast submission processes for Canada and Latin America and provides C-suite executives with monthly and quarterly performance analysis on revenue and expenses. Additionally, he supervises revenue accruals related to rebates and other revenue adjustments for the USA.
Throughout his career, Mr. Luthy has led commercial go-direct strategy, setting up a new organization from the ground up that exceeded financial expectations and delivered significant incremental margin, and served as a key participant of two major and highly successful integrations while focusing on business continuity, talent retention, and system integration. He has developed and led high-performing teams, promoted key talents, encouraged cross-cultural experiences, and successfully executed key projects.
Looking back, Mr. Luthy attributes his success to a strong work ethic matched with working well with others and understanding that there are multiple solutions to a problem. He has provided strategic financial leadership and direction to the new Americas division at Medtronic following the acquisition of Covidien, transformed Latin American finance into a highly-respected business partner, and implemented ERPs across Latin America, thereby improving controls, automation, and process. Professionally Mr. Luthy maintains affiliation with the NAW-Miami, GAMD, and the Americas Society and Council of the Americas.
Considering the future, Mr. Luthy’s long-terms goals include continuing to act as a valuable finance business partner by driving growth in markets through partnership across functions, businesses, and geographies.
In his free time, Mr. Luthy enjoys mentoring others, especially regarding their career goals.
For more information, please contact: Elizabeth Moore American Health Council Hauppauge, NY United States Phone: 1-212-390-0214 Email: [email protected]


Kia Cuts EV Prices in Europe as Chinese Carmakers Intensify Competition
U.S. Warns Allies Over Alleged Chinese AI IP Theft Linked to DeepSeek
$16B Michigan Data Center Project Boosts U.S. AI Infrastructure Expansion
DeepSeek Slashes AI Model Pricing to Boost Adoption and Challenge Global Rivals
Toyota Global Vehicle Sales Decline in March Amid RAV4 Transition and Middle East Slowdown
U.S. Demand for Alternative Satellite Providers Remains Strong Amid SpaceX Regulatory Push
Sun Pharma to Acquire Organon in $11.75 Billion Deal to Boost Global Women’s Health Portfolio
DeepSeek V4 Launch Signals China’s Growing AI Independence with Huawei Chips
Brazil Pension Fund Crackdown After Banco Master Collapse Raises Investment Concerns
Why Global Web3 Projects Can't Afford to Skip South Korea: TokenPost Unveils Data-Driven Entry Solutions
SMC Corp Stock Surges as Palliser Capital Pushes for Major Share Buyback
Microsoft Commits $18 Billion to Expand AI and Cloud Infrastructure in Australia
Judge Dismisses Elon Musk’s Fraud Claims Against OpenAI, Trial to Proceed on Remaining Allegations
Intel Stock Surges as AI Chip Demand Drives Strong Q2 Forecast
Chinese Chip Stocks Surge on AI Boom and Domestic Tech Push
U.S. Raises Alarm Over Chinese AI Firms’ Alleged IP Theft Through Model Distillation 



